1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Mayne Pharma Group Limited
  6. Calendar
    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart MAYNE PHARMA GROUP LIMITED
Upcoming events on MAYNE PHARMA GROUP LIMITED
08/25/22 FY 2022 Earnings Release (Projected)
02/24/23 Interim 2023 Earnings Release (Projected)
08/25/23 FY 2023 Earnings Release (Projected)
02/23/24 Interim 2024 Earnings Release (Projected)
Past events on MAYNE PHARMA GROUP LIMITED
02/24/22 | 05:30pm Interim 2022 Earnings Call
02/24/22 | 04:09pm Interim 2022 Earnings Release
11/22/21 | 05:00pm Annual General Meeting
08/26/21 | 07:00pm FY 2021 Earnings Call
08/26/21 | 06:09pm FY 2021 Earnings Release
02/24/21 Interim 2021 Earnings Release
02/23/21 | 05:00pm Interim 2021 Earnings Call
11/23/20 | 06:00pm Annual General Meeting
08/20/20 | 07:00pm FY 2020 Earnings Call
08/20/20 | 06:16pm FY 2020 Earnings Release
Past dividends on MAYNE PHARMA GROUP LIMITED

- No events available -

Annual results
Fiscal Period : June201720182019202020212022
Sales
M AUD
Released
Forecast
Spread
573
597
-4,0%
530
532
-0,33%
525
525
-0,04%
457
455
0,42%
401
416
-3,6%
 
403
 
Operating income
(EBITDA)
M AUD
Released
Forecast
Spread
207
217
-5,0%
165
145
14%
131
135
-2,8%
95,3
87,8
8,6%
63,5
67,4
-5,8%
 
40,4
 
Operating profit
(EBIT)
M AUD
Released
Forecast
Spread
133
151
-12%
86,2
74,3
16%
37,2
43,3
-14%
11,7
12,8
-8,9%
-3,70
-15,3
76%
 
-56,6
 
Pre-Tax Profit
(EBT)
M AUD
Released
Forecast
Spread
116
138
-16%
-167
-57,3
-191%
-354
27,0
-1 410%
-135
-37,5
-261%
-264
-258
-2,2%
 
-109
 
Net income
M AUD
Released
Forecast
Spread
88,6
100
-12%
-134
-153
12%
-281
11,2
-2 599%
-92,8
-33,3
-178%
-208
-173
-21%
 
-75,3
 
EPS
AUD
Released
Forecast
Spread
0,06
0,07
-9,0%
-0,09
-0,10
5,9%
-0,19
0,01
-2 332%
-0,06
-0,01
-327%
-0,13
-0,09
-41%
 
-0,05
 
Announcement Date08/24/201708/23/201808/22/201908/20/202008/26/2021-
Quarterly results
Fiscal Period : June2020 S12020 S22021 S12021 S22022 S12022 S2
Sales
M AUD
Released
Forecast
Spread
227
237
-4,0%
230
221
3,9%
209
209
0,10%
192
205
-6,5%
196
205
-4,6%
 
193
 
Operating income
(EBITDA)
M AUD
Released
Forecast
Spread
47,4
40,6
17%
47,9
40,1
19%
39,9
44,9
-11%
23,6
23,0
2,6%
23,7
23,4
1,5%
 
11,7
 
Operating profit
(EBIT)
M AUD
Released
Forecast
Spread
-12,3
3,00
-510%
24,0
4,80
400%
2,30
2,75
-16%
-6,00
-16,9
64%
-17,6
-12,2
-45%
 
-49,1
 
Pre-Tax Profit
(EBT)
M AUD
Released
Forecast
Spread
-25,0
-4,35
-474%
-110
-13,5
-718%
-229
-12,3
-1 771%
-34,6
-27,1
-28%
-63,7
-21,1
-202%
 
-45,1
 
Net income
M AUD
Released
Forecast
Spread
-17,5
-3,25
-438%
-75,3
-14,0
-440%
-181
-8,70
-1 984%
-27,1
-18,7
-45%
-50,4
-14,8
-241%
 
-45,1
 
EPS
Released
Forecast
Spread
-0,01
-0,00
-173%


 
-0,12
-0,01
-1 511%
-0,02
-0,01
-43%
-0,03
-0,01
-248%
 

 
Announcement Date02/20/202008/20/202002/23/202108/26/202102/24/2022-
Previous year Next Year
Upcoming sector events for MAYNE PHARMA GROUP LIMITED
More events
Past sector events for MAYNE PHARMA GROUP LIMITED
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise